Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Xiufei Lin"'
Autor:
Peng Cheng, Fangfang Zhang, Lechu Yu, Xiufei Lin, Luqing He, Xiaokun Li, Xuemian Lu, Xiaoqing Yan, Yi Tan, Chi Zhang
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications. The heart is a key target as
Externí odkaz:
https://doaj.org/article/eaf169dce07945c0a5f80f16e311e63c
Autor:
Chi Zhang, Xiufei Lin, Hong Yang, Dingliang Qian, Peng Cheng, Weihua Li, Fangfang Zhang, Luqing He, Lechu Yu
Publikováno v:
Journal of Cellular and Molecular Medicine
We investigated whether low‐dose radiation (LDR) can prevent late‐stage diabetic cardiomyopathy and whether this protection is because of the induction of anti‐apoptotic and anti‐oxidant pathways. Streptozotocin‐induced diabetic C57BL/6J mi
Autor:
Hong Yang, Xuemian Lu, Fangfang Zhang, Peng Cheng, Yi Tan, Xiaokun Li, Lu Cai, Xiufei Lin, Chi Zhang, Luqing He, Lechu Yu
Publikováno v:
Molecular Endocrinology. 29:1400-1413
Fibroblast growth factor (FGF)19 and FGF21 are hormones that regulate metabolic processes particularly during feeding or starvation, thus ultimately influencing energy production. FGF19 is secreted by the intestines during feeding and negatively regu
Autor:
Xiaoqing Yan, Chi Zhang, Lechu Yu, Anyun Feng, Hong Yang, Xiufei Lin, Xuemian Lu, Sundong Lin
Publikováno v:
Cell Death and Disease, Vol 9, Iss 2, Pp 1-14 (2018)
Cell Death & Disease
Cell Death & Disease
Our previous studies showed that both exogenous and endogenous FGF21 inhibited cardiac apoptosis at the early stage of type 1 diabetes. Whether FGF21 induces preventive effect on type 2 diabetes-induced cardiomyopathy was investigated in the present
Autor:
Xiaokun Li, Xiufei Lin, Xiaoqing Yan, Chi Zhang, Fangfang Zhang, Peng Cheng, Yi Tan, Xuemian Lu, Luqing He, Lechu Yu
Publikováno v:
Journal of Diabetes Research, Vol 2016 (2016)
Journal of Diabetes Research
Journal of Diabetes Research
Cardiovascular disease (CVD) is one of the most severe diseases in clinics. Fibroblast growth factor 21 (FGF21) is regarded as an important metabolic regulator playing a therapeutic role in diabetes and its complications. The heart is a key target as
Autor:
Minglong Shao, Lechu Yu, Fangfang Zhang, Xuemian Lu, Xiaokun Li, Peng Cheng, Xiufei Lin, Luqing He, Shunzi Jin, Yi Tan, Hong Yang, Chi Zhang, Lu Cai
Publikováno v:
American Journal of Physiology: Endocrinology & Metabolism; 7/1/2015, Vol. 309 Issue 1, pE45-E54, 10p